Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 19 | 0 | 0 | 19 |
5-hydroxytryptamine receptor 3E | 0 | 7 | 0 | 7 |
acetylcholinesterase | 25 | 0 | 0 | 25 |
TDP1 protein | 64 | 0 | 0 | 64 |
cytochrome P450 2D6 | 49 | 0 | 0 | 49 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 28 | 0 | 0 | 28 |
cytochrome P450 2D6 isoform 1 | 30 | 0 | 0 | 30 |
cellular tumor antigen p53 isoform a | 14 | 0 | 0 | 14 |
cytochrome P450 2C19 precursor | 20 | 0 | 0 | 20 |
cytochrome P450 2C9 precursor | 13 | 0 | 0 | 13 |
thyroid hormone receptor beta isoform a | 15 | 0 | 0 | 15 |
thyroid hormone receptor beta isoform 2 | 46 | 0 | 0 | 46 |
huntingtin isoform 2 | 9 | 0 | 0 | 9 |
peripheral myelin protein 22 | 38 | 0 | 0 | 38 |
cytochrome P450 3A4 isoform 1 | 26 | 0 | 0 | 26 |
muscarinic acetylcholine receptor M1 | 35 | 0 | 0 | 35 |
Gamma-aminobutyric acid receptor subunit pi | 26 | 13 | 3 | 42 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 19 | 0 | 0 | 19 |
ATP-binding cassette sub-family C member 3 | 0 | 53 | 0 | 53 |
Multidrug resistance-associated protein 4 | 0 | 53 | 0 | 53 |
5-hydroxytryptamine receptor 3B | 0 | 7 | 0 | 7 |
Bile salt export pump | 0 | 84 | 0 | 84 |
Beta-1 adrenergic receptor | 0 | 4 | 1 | 5 |
5-hydroxytryptamine receptor 1A | 0 | 20 | 9 | 29 |
5-hydroxytryptamine receptor 2C | 0 | 27 | 5 | 32 |
D(2) dopamine receptor | 0 | 60 | 8 | 76 |
5-hydroxytryptamine receptor 2A | 0 | 32 | 7 | 39 |
Gamma-aminobutyric acid receptor subunit beta-1 | 26 | 13 | 3 | 42 |
Alpha-1B adrenergic receptor | 0 | 34 | 3 | 37 |
Gamma-aminobutyric acid receptor subunit delta | 26 | 13 | 3 | 42 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 26 | 13 | 5 | 44 |
D | 0 | 25 | 0 | 25 |
5-hydroxytryptamine receptor 1A | 0 | 55 | 5 | 61 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 26 | 13 | 3 | 42 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 26 | 13 | 3 | 42 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 26 | 13 | 3 | 42 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 26 | 13 | 3 | 42 |
Alpha-1D adrenergic receptor | 0 | 27 | 3 | 30 |
5-hydroxytryptamine receptor 2A | 0 | 66 | 7 | 76 |
5-hydroxytryptamine receptor 2C | 0 | 64 | 5 | 69 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 26 | 13 | 3 | 42 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 26 | 13 | 3 | 42 |
5-hydroxytryptamine receptor 1B | 0 | 45 | 3 | 48 |
5-hydroxytryptamine receptor 1D | 0 | 13 | 3 | 16 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 26 | 13 | 3 | 42 |
5-hydroxytryptamine receptor 1F | 0 | 13 | 3 | 16 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 24 | 5 | 29 |
Sodium-dependent serotonin transporter | 0 | 62 | 7 | 69 |
5-hydroxytryptamine receptor 7 | 0 | 16 | 3 | 19 |
5-hydroxytryptamine receptor 7 | 0 | 17 | 1 | 18 |
Alpha-1B adrenergic receptor | 0 | 10 | 2 | 13 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 11 | 2 | 17 |
5-hydroxytryptamine receptor 2B | 0 | 60 | 4 | 64 |
Alpha-1A adrenergic receptor | 0 | 38 | 4 | 42 |
5-hydroxytryptamine receptor 3A | 0 | 9 | 0 | 9 |
Histamine H2 receptor | 27 | 5 | 1 | 39 |
5-hydroxytryptamine receptor 6 | 0 | 50 | 1 | 52 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 38 | 3 | 42 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 26 | 14 | 5 | 45 |
Gamma-aminobutyric acid receptor subunit beta-3 | 26 | 13 | 3 | 42 |
Gamma-aminobutyric acid receptor subunit beta-2 | 26 | 13 | 5 | 44 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 11 | 2 | 17 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 12 | 2 | 18 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 11 | 2 | 18 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 11 | 2 | 17 |
5-hydroxytryptamine receptor 3D | 0 | 7 | 0 | 7 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 11 | 2 | 17 |
5-hydroxytryptamine receptor 3C | 0 | 7 | 0 | 7 |
GABA theta subunit | 26 | 13 | 3 | 42 |
Canalicular multispecific organic anion transporter 1 | 0 | 52 | 0 | 52 |
Gamma-aminobutyric acid receptor subunit epsilon | 26 | 13 | 3 | 42 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 11 | 2 | 17 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 26 | 0 | 0 | 26 |
Chain A, HADH2 protein | 16 | 0 | 0 | 16 |
Chain B, HADH2 protein | 16 | 0 | 0 | 16 |
RAR-related orphan receptor gamma | 35 | 0 | 0 | 35 |
GLI family zinc finger 3 | 46 | 0 | 0 | 46 |
AR protein | 56 | 0 | 0 | 56 |
aldehyde dehydrogenase 1 family, member A1 | 24 | 0 | 0 | 24 |
thyroid stimulating hormone receptor | 36 | 0 | 0 | 36 |
estrogen receptor 2 (ER beta) | 22 | 0 | 0 | 22 |
nuclear receptor subfamily 1, group I, member 3 | 35 | 0 | 0 | 35 |
progesterone receptor | 27 | 0 | 0 | 27 |
glucocorticoid receptor [Homo sapiens] | 45 | 0 | 0 | 45 |
retinoic acid nuclear receptor alpha variant 1 | 36 | 0 | 0 | 36 |
estrogen-related nuclear receptor alpha | 43 | 0 | 0 | 43 |
pregnane X nuclear receptor | 40 | 0 | 0 | 40 |
estrogen nuclear receptor alpha | 58 | 0 | 0 | 58 |
aryl hydrocarbon receptor | 21 | 0 | 0 | 21 |
thyroid stimulating hormone receptor | 26 | 0 | 0 | 26 |
activating transcription factor 6 | 11 | 0 | 0 | 11 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 20 | 0 | 0 | 20 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 7 | 0 | 0 | 7 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 41 | 0 | 0 | 41 |
Voltage-dependent calcium channel gamma-2 subunit | 17 | 0 | 0 | 17 |
Glutamate receptor 2 | 18 | 2 | 2 | 22 |
Kelch-like ECH-associated protein 1 | 0 | 0 | 1 | 1 |
Histone acetyltransferase KAT8 | 0 | 1 | 0 | 1 |
regulator of G-protein signaling 4 | 36 | 0 | 0 | 36 |
Histamine H2 receptor | 0 | 32 | 4 | 36 |
Histamine H4 receptor | 0 | 6 | 5 | 11 |
Histamine H3 receptor | 0 | 2 | 0 | 5 |
Histamine H3 receptor | 0 | 13 | 3 | 16 |
Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 6 | 0 | 0 | 6 |
Chain A, Ferritin light chain | 7 | 0 | 0 | 7 |
Thymidine kinase | 0 | 1 | 0 | 1 |
thioredoxin reductase | 42 | 0 | 0 | 42 |
phosphopantetheinyl transferase | 24 | 0 | 0 | 24 |
GLS protein | 43 | 0 | 0 | 43 |
Smad3 | 13 | 0 | 0 | 13 |
EWS/FLI fusion protein | 23 | 0 | 0 | 23 |
arylsulfatase A | 35 | 0 | 0 | 35 |
euchromatic histone-lysine N-methyltransferase 2 | 72 | 0 | 0 | 72 |
Histone H2A.x | 15 | 0 | 0 | 15 |
Bloom syndrome protein isoform 1 | 23 | 0 | 0 | 23 |
hemoglobin subunit beta | 3 | 0 | 0 | 3 |
atrial natriuretic peptide receptor 1 precursor | 8 | 0 | 0 | 8 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 9 | 0 | 0 | 9 |
lamin isoform A-delta10 | 45 | 0 | 0 | 45 |
Solute carrier family 22 member 1 | 0 | 23 | 0 | 29 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
Bile salt export pump | 0 | 11 | 0 | 11 |
Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 19 | 0 | 20 |
Cytochrome P450 2J2 | 0 | 16 | 0 | 17 |
Disintegrin and metalloproteinase domain-containing protein 17 | 6 | 0 | 0 | 6 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 1 |
NFKB1 protein, partial | 16 | 0 | 0 | 16 |
signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
putative alpha-glucosidase | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 12 | 0 | 0 | 12 |
histone acetyltransferase KAT2A isoform 1 | 21 | 0 | 0 | 21 |
Solute carrier family 22 member 2 | 0 | 7 | 0 | 11 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 5 | 0 | 5 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 5 | 0 | 5 |
Matrix protein 2 | 0 | 1 | 1 | 2 |
Matrix protein 2 | 0 | 1 | 2 | 3 |
Spike glycoprotein | 31 | 3 | 8 | 42 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 6 | 0 | 6 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 6 | 0 | 6 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 6 | 0 | 6 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 5 | 0 | 5 |
Solute carrier family 22 member 1 | 0 | 10 | 0 | 14 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 5 | 0 | 5 |
Multidrug and toxin extrusion protein 1 | 0 | 6 | 0 | 6 |
Solute carrier family 22 member 2 | 0 | 7 | 0 | 10 |
ATP-dependent phosphofructokinase | 38 | 0 | 0 | 38 |
USP1 protein, partial | 27 | 0 | 0 | 27 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 43 | 0 | 0 | 43 |
D(1A) dopamine receptor | 38 | 0 | 0 | 38 |
chromobox protein homolog 1 | 40 | 0 | 0 | 40 |
atrial natriuretic peptide receptor 2 precursor | 18 | 0 | 0 | 18 |
serine/threonine-protein kinase mTOR isoform 1 | 23 | 0 | 0 | 23 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 13 | 0 | 13 |
5-hydroxytryptamine receptor 4 | 0 | 54 | 0 | 54 |
Albumin | 0 | 0 | 11 | 11 |
High affinity nerve growth factor receptor | 0 | 1 | 2 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 39 | 0 | 39 |
Muscarinic acetylcholine receptor M2 | 0 | 49 | 8 | 63 |
Muscarinic acetylcholine receptor M4 | 0 | 51 | 6 | 61 |
Muscarinic acetylcholine receptor M1 | 0 | 23 | 3 | 30 |
Muscarinic acetylcholine receptor M3 | 0 | 20 | 3 | 26 |
Muscarinic acetylcholine receptor M4 | 0 | 20 | 2 | 25 |
Muscarinic acetylcholine receptor M5 | 0 | 19 | 2 | 24 |
Muscarinic acetylcholine receptor M5 | 0 | 50 | 5 | 59 |
Alpha-2A adrenergic receptor | 0 | 62 | 5 | 68 |
Muscarinic acetylcholine receptor M2 | 0 | 23 | 3 | 30 |
Muscarinic acetylcholine receptor M1 | 0 | 55 | 9 | 71 |
Angiotensin-converting enzyme | 0 | 30 | 0 | 30 |
Alpha-2B adrenergic receptor | 0 | 61 | 3 | 65 |
Alpha-2C adrenergic receptor | 0 | 54 | 4 | 59 |
Muscarinic acetylcholine receptor M3 | 0 | 53 | 7 | 64 |
D(1A) dopamine receptor | 0 | 44 | 2 | 49 |
D(1B) dopamine receptor | 0 | 12 | 0 | 15 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 6 |
Sodium-dependent noradrenaline transporter | 0 | 54 | 6 | 60 |
Alpha-1D adrenergic receptor | 0 | 46 | 2 | 49 |
5-hydroxytryptamine receptor 6 | 0 | 7 | 3 | 10 |
Histamine H1 receptor | 0 | 12 | 1 | 13 |
5-hydroxytryptamine receptor 5A | 0 | 7 | 3 | 10 |
5-hydroxytryptamine receptor 5B | 0 | 7 | 3 | 10 |
Histamine H1 receptor | 0 | 51 | 6 | 60 |
D(3) dopamine receptor | 0 | 55 | 6 | 69 |
Sodium channel protein type 1 subunit alpha | 0 | 7 | 0 | 7 |
Sodium channel protein type 4 subunit alpha | 0 | 8 | 0 | 11 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 9 | 3 | 12 |
D(1A) dopamine receptor | 17 | 1 | 0 | 18 |
5-hydroxytryptamine receptor 7 | 0 | 15 | 0 | 15 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 7 | 0 | 7 |
Sodium channel protein type 7 subunit alpha | 0 | 5 | 0 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 13 | 0 | 13 |
Sodium-dependent dopamine transporter | 0 | 43 | 4 | 47 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 54 | 0 | 54 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 13 | 0 | 13 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 15 | 0 | 16 |
Sodium channel protein type 5 subunit alpha | 0 | 12 | 0 | 12 |
Sodium channel protein type 9 subunit alpha | 0 | 9 | 0 | 9 |
Sigma non-opioid intracellular receptor 1 | 0 | 9 | 3 | 12 |
5-hydroxytryptamine receptor 4 | 0 | 7 | 3 | 10 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 29 | 0 | 29 |
Sodium channel protein type 2 subunit alpha | 0 | 8 | 0 | 8 |
Ataxin-2 | 37 | 0 | 0 | 37 |
Sigma non-opioid intracellular receptor 1 | 0 | 54 | 1 | 55 |
5-hydroxytryptamine receptor 3B | 0 | 9 | 3 | 12 |
Sodium channel protein type 3 subunit alpha | 0 | 8 | 0 | 8 |
Sodium channel protein type 11 subunit alpha | 0 | 5 | 0 | 5 |
Sodium channel protein type 8 subunit alpha | 0 | 5 | 0 | 5 |
Sodium channel protein type 10 subunit alpha | 0 | 6 | 0 | 6 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
Phenylethanolamine N-methyltransferase | 0 | 3 | 0 | 3 |
Cytochrome P450 2A6 | 0 | 5 | 1 | 6 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Cytochrome P450 2A5 | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 25 | 1 | 26 |
Beta-2 adrenergic receptor | 0 | 4 | 1 | 7 |
Sigma non-opioid intracellular receptor 1 | 0 | 13 | 2 | 15 |
vitamin D3 receptor isoform VDRA | 18 | 0 | 0 | 18 |
Translocator protein | 0 | 3 | 2 | 6 |
Vasopressin V2 receptor | 0 | 3 | 2 | 6 |
Oxytocin receptor | 0 | 3 | 3 | 6 |
Vasopressin V1a receptor | 0 | 1 | 2 | 3 |
Vasopressin V1a receptor | 0 | 4 | 3 | 7 |
Vasopressin V1b receptor | 0 | 2 | 2 | 4 |
Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
Vasopressin V1b receptor | 0 | 2 | 1 | 4 |
Translocator protein | 0 | 1 | 0 | 2 |
Oxytocin receptor | 0 | 2 | 0 | 2 |
Vasopressin V2 receptor | 0 | 2 | 1 | 3 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 13 | 0 | 0 | 13 |
hypoxia-inducible factor 1 alpha subunit | 15 | 0 | 0 | 15 |
SMAD family member 2 | 6 | 0 | 0 | 6 |
Fumarate hydratase | 19 | 0 | 0 | 19 |
PPM1D protein | 6 | 0 | 0 | 6 |
SMAD family member 3 | 6 | 0 | 0 | 6 |
Microtubule-associated protein tau | 24 | 0 | 0 | 24 |
retinoid X nuclear receptor alpha | 25 | 0 | 0 | 25 |
farnesoid X nuclear receptor | 22 | 0 | 0 | 22 |
G | 19 | 0 | 0 | 19 |
polyprotein | 19 | 0 | 0 | 19 |
67.9K protein | 15 | 0 | 0 | 15 |
peroxisome proliferator-activated receptor delta | 26 | 0 | 0 | 26 |
peroxisome proliferator activated receptor gamma | 24 | 0 | 0 | 24 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 19 | 0 | 0 | 19 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 7 | 0 | 0 | 7 |
lysosomal alpha-glucosidase preproprotein | 4 | 0 | 0 | 4 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 2 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 11 | 0 | 0 | 11 |
potassium voltage-gated channel subfamily H member 2 isoform d | 35 | 0 | 0 | 35 |
transcriptional regulator ERG isoform 3 | 7 | 0 | 0 | 7 |
nuclear receptor ROR-gamma isoform 1 | 16 | 0 | 0 | 16 |
geminin | 46 | 0 | 0 | 46 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 2 | 2 |
neuropeptide S receptor isoform A | 7 | 0 | 0 | 7 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 1 | 3 |
Interferon beta | 26 | 0 | 0 | 26 |
HLA class I histocompatibility antigen, B alpha chain | 19 | 0 | 0 | 19 |
Cellular tumor antigen p53 | 30 | 0 | 0 | 30 |
ATP-dependent translocase ABCB1 | 0 | 22 | 0 | 29 |
Cytochrome P450 3A4 | 0 | 20 | 0 | 22 |
Neuronal acetylcholine receptor subunit alpha-4 | 2 | 6 | 2 | 11 |
Neuronal acetylcholine receptor subunit beta-2 | 2 | 6 | 2 | 11 |
D(4) dopamine receptor | 0 | 26 | 2 | 33 |
D(4) dopamine receptor | 0 | 18 | 0 | 18 |
Histamine H1 receptor | 0 | 6 | 3 | 10 |
Alpha-1A adrenergic receptor | 0 | 14 | 3 | 18 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 5 | 0 | 5 |
Inositol monophosphatase 1 | 17 | 0 | 0 | 17 |
Multidrug and toxin extrusion protein 2 | 0 | 4 | 0 | 4 |
Inositol hexakisphosphate kinase 1 | 19 | 0 | 0 | 19 |
cytochrome P450 2C9, partial | 19 | 0 | 0 | 19 |
lethal factor (plasmid) | 20 | 0 | 0 | 20 |
Metabotropic glutamate receptor 6 | 0 | 1 | 2 | 4 |
Excitatory amino acid transporter 4 | 0 | 2 | 0 | 2 |
Glutamate transporter homolog | 0 | 0 | 1 | 1 |
Carbonic anhydrase 1 | 0 | 9 | 0 | 18 |
Carbonic anhydrase 2 | 0 | 9 | 1 | 20 |
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 3 | 0 | 5 |
Excitatory amino acid transporter 1 | 0 | 3 | 0 | 4 |
Excitatory amino acid transporter 2 | 0 | 3 | 0 | 4 |
Excitatory amino acid transporter 3 | 0 | 3 | 0 | 4 |
Metabotropic glutamate receptor 1 | 0 | 1 | 2 | 4 |
Metabotropic glutamate receptor 2 | 0 | 1 | 2 | 4 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 7 |
Carbonic anhydrase 4 | 0 | 3 | 0 | 5 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 16 | 0 | 0 | 16 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 5 | 0 | 0 | 5 |
hypothetical protein, conserved | 3 | 0 | 0 | 3 |
glucocerebrosidase | 10 | 0 | 0 | 10 |
Rac1 protein | 0 | 0 | 1 | 1 |
IDH1 | 20 | 0 | 0 | 20 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
DNA polymerase iota isoform a (long) | 17 | 0 | 0 | 17 |
DNA polymerase kappa isoform 1 | 14 | 0 | 0 | 14 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 7 | 0 | 7 |
Fatty acid-binding protein, liver | 0 | 4 | 0 | 4 |
Integrin beta-3 | 11 | 1 | 1 | 13 |
Myeloperoxidase | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 11 | 1 | 1 | 13 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 3 | 0 | 3 |
Adenosine receptor A1 | 0 | 7 | 0 | 11 |
Adenosine receptor A2a | 0 | 4 | 1 | 10 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 7 | 0 | 0 | 7 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
glp-1 receptor, partial | 20 | 0 | 0 | 20 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 7 | 0 | 0 | 7 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 2 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 3 | 7 |
Muscarinic acetylcholine receptor M4 | 0 | 3 | 1 | 5 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 5 | 2 | 8 |
ATAD5 protein, partial | 27 | 0 | 0 | 27 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 2 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 12 | 0 | 0 | 12 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 5 | 0 | 0 | 5 |
Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
Spike glycoprotein | 0 | 3 | 8 | 11 |
Replicase polyprotein 1ab | 0 | 3 | 8 | 11 |
Transmembrane protease serine 2 | 0 | 3 | 8 | 11 |
Procathepsin L | 0 | 3 | 8 | 11 |
Replicase polyprotein 1a | 0 | 3 | 8 | 11 |
Replicase polyprotein 1ab | 0 | 3 | 8 | 11 |
Replicase polyprotein 1ab | 0 | 5 | 8 | 13 |
Replicase polyprotein 1ab | 0 | 7 | 8 | 15 |
Sodium-dependent serotonin transporter | 0 | 15 | 2 | 18 |
Angiotensin-converting enzyme 2 | 0 | 3 | 8 | 11 |
importin subunit beta-1 isoform 1 | 8 | 0 | 0 | 8 |
snurportin-1 | 8 | 0 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 12 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 12 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 13 | 4 | 17 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 12 | 2 | 14 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 13 | 3 | 16 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 13 | 3 | 16 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 13 | 4 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 13 | 3 | 16 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 13 | 3 | 16 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 12 | 3 | 15 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 12 | 2 | 14 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 12 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 12 | 2 | 14 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 12 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 12 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 12 | 0 | 12 |
Acetylcholine receptor subunit alpha | 0 | 3 | 1 | 4 |
Acetylcholine receptor subunit gamma | 0 | 3 | 1 | 4 |
Integrin alpha-5 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta | 0 | 3 | 1 | 4 |
UDP-glucuronosyltransferase 2B7 | 0 | 3 | 0 | 7 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 3 | 1 | 5 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 2 |
Cytochrome P450 2B6 | 0 | 2 | 1 | 5 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 3 | 1 | 5 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 3 | 1 | 4 |
Cytochrome P450 2C19 | 0 | 10 | 0 | 11 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 3 | 2 | 5 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 3 | 1 | 5 |
Acetylcholine receptor subunit delta | 0 | 3 | 1 | 4 |
Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Chitinase | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 6 | 6 | 12 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 8 | 0 | 8 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 8 | 1 | 9 |
Amine oxidase [flavin-containing] A | 0 | 9 | 0 | 9 |
Acetylcholinesterase | 0 | 9 | 3 | 14 |
Amine oxidase [flavin-containing] B | 0 | 10 | 1 | 11 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 3 | 0 | 3 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 4 | 2 | 7 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Adenosine receptor A2b | 0 | 2 | 1 | 4 |
Adenosine receptor A1 | 0 | 6 | 1 | 9 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
DNA-dependent protein kinase catalytic subunit | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
Chitotriosidase-1 | 0 | 1 | 0 | 1 |
Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 2 | 3 |
Endochitinase B1 | 0 | 1 | 0 | 1 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 5 | 0 | 5 |
Guanine deaminase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 9 | 0 | 10 |
L-lactate dehydrogenase A chain | 0 | 2 | 0 | 2 |
Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 6 | 1 | 7 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 27 | 1 | 30 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
Cannabinoid receptor 1 | 0 | 3 | 1 | 4 |
Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 5 | 1 | 8 |
Cytochrome P450 3A7 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 0 | 1 | 1 |
Cannabinoid receptor 2 | 0 | 3 | 2 | 7 |
Mu-type opioid receptor | 0 | 23 | 8 | 34 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 3 | 3 |
Delta-type opioid receptor | 0 | 17 | 5 | 25 |
Kappa-type opioid receptor | 0 | 18 | 5 | 27 |
Cholinesterase | 0 | 8 | 0 | 9 |
N-acylethanolamine-hydrolyzing acid amidase | 0 | 1 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 3 | 0 | 3 |
Heat sensitive channel TRPV3 | 0 | 1 | 1 | 2 |
Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 2 | 3 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 1 | 2 |
Transient receptor potential cation channel subfamily M member 8 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 2 | 1 | 3 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 2 | 1 | 3 |
G-protein coupled receptor 55 | 0 | 1 | 2 | 3 |
Diacylglycerol lipase-alpha | 0 | 1 | 0 | 1 |
Chain A, Beta-lactamase | 12 | 0 | 0 | 12 |
GALC protein | 9 | 0 | 0 | 9 |
thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 4 | 2 | 7 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 4 | 2 | 7 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 4 | 2 | 7 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 4 | 2 | 7 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 4 | 2 | 7 |
Delta-type opioid receptor | 0 | 14 | 2 | 20 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 4 | 2 | 7 |
Neuronal acetylcholine receptor subunit alpha-9 | 0 | 4 | 2 | 7 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 6 | 2 | 9 |
Muscarinic acetylcholine receptor M3 | 0 | 1 | 2 | 6 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 6 |
Neuronal acetylcholine receptor subunit alpha-10 | 0 | 4 | 2 | 7 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 20 | 0 | 0 | 20 |
mitogen-activated protein kinase 1 | 23 | 0 | 0 | 23 |
Vpr | 3 | 0 | 0 | 3 |
Major prion protein | 0 | 0 | 5 | 5 |
Sodium channel protein type 1 subunit alpha | 0 | 5 | 0 | 5 |
Sodium channel protein type 2 subunit alpha | 0 | 8 | 0 | 8 |
Sodium channel protein type 3 subunit alpha | 0 | 4 | 0 | 4 |
Frizzled-8 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 3 | 0 | 3 |
pregnane X receptor | 6 | 0 | 0 | 6 |
Cytochrome P450 2E1 | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 11 | 0 | 0 | 11 |
Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 12 | 0 | 3 | 0 | 8 |
Carbonic anhydrase 3 | 0 | 3 | 0 | 7 |
Neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 3 | 0 | 8 |
Carbonic anhydrase 6 | 0 | 3 | 0 | 8 |
Carbonic anhydrase 5A, mitochondrial | 0 | 3 | 1 | 9 |
Carbonic anhydrase 7 | 0 | 3 | 0 | 8 |
Carbonic anhydrase 9 | 0 | 3 | 0 | 9 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 4 |
Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 7 |
Carbonic anhydrase 5B, mitochondrial | 0 | 3 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 4 | 0 | 5 |
Cholecystokinin receptor type A | 0 | 3 | 0 | 3 |
Gastrin/cholecystokinin type B receptor | 0 | 3 | 0 | 3 |
Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
Thrombopoietin | 16 | 0 | 0 | 16 |
caspase 7, apoptosis-related cysteine protease | 11 | 0 | 0 | 11 |
NADPH oxidase 1 | 0 | 4 | 0 | 4 |
Snq2p | 0 | 0 | 0 | 11 |
caspase-3 | 11 | 0 | 0 | 11 |
Adenylate cyclase type 1 | 0 | 4 | 0 | 4 |
Caspase-7 | 7 | 0 | 0 | 7 |
caspase-3 | 7 | 0 | 0 | 7 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
ras-related protein Rab-9A | 12 | 0 | 0 | 12 |
survival motor neuron protein isoform d | 16 | 0 | 0 | 16 |
M-phase phosphoprotein 8 | 19 | 0 | 0 | 19 |
Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 5 | 7 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 3 | 0 | 3 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
Major prion protein | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase Fyn | 0 | 5 | 0 | 5 |
Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 4 | 2 | 6 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 4 | 0 | 4 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 22 | 1 | 23 |
Alpha-2B adrenergic receptor | 0 | 18 | 3 | 21 |
D(2) dopamine receptor | 0 | 7 | 0 | 7 |
Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
Substance-K receptor | 0 | 4 | 0 | 4 |
Adenylate cyclase type 3 | 0 | 4 | 0 | 4 |
Alpha-2C adrenergic receptor | 0 | 18 | 3 | 21 |
Alpha-2A adrenergic receptor | 0 | 18 | 3 | 21 |
D(1B) dopamine receptor | 0 | 16 | 0 | 16 |
Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 4 | 0 | 4 |
Adenylate cyclase type 4 | 0 | 4 | 0 | 4 |
Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
Trypanothione reductase | 0 | 14 | 0 | 14 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
Melanocortin receptor 5 | 0 | 6 | 0 | 6 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 11 | 0 | 22 |
Adenylate cyclase type 8 | 0 | 4 | 0 | 4 |
Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 3 | 0 | 3 |
Proteasome subunit alpha type-6 | 0 | 0 | 4 | 5 |
Calmodulin | 0 | 1 | 4 | 5 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 6 | 0 | 4 | 0 | 4 |
Adenylate cyclase type 5 | 0 | 4 | 0 | 4 |
Aldehyde oxidase | 0 | 3 | 0 | 5 |
Adenylyl cyclase 7 | 0 | 4 | 0 | 4 |
Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
D | 0 | 7 | 0 | 7 |
Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein | 0 | 0 | 1 | 1 |
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
Chain A, Choline-binding protein | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
Choline O-acetyltransferase | 0 | 2 | 0 | 3 |
High affinity choline transporter 1 | 0 | 1 | 0 | 1 |
Trypanothione reductase | 0 | 1 | 0 | 1 |
Envelope glycoprotein | 0 | 0 | 3 | 3 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
Translocator protein | 0 | 2 | 0 | 2 |
Translocator protein | 0 | 3 | 0 | 3 |
Chain A, Cruzipain | 2 | 0 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 2 | 2 | 5 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 4 | 0 | 5 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 2 |
Mu-type opioid receptor | 0 | 10 | 2 | 13 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Nischarin | 0 | 3 | 0 | 3 |
Nischarin | 0 | 2 | 0 | 2 |
Luciferase | 14 | 0 | 0 | 14 |
bromodomain adjacent to zinc finger domain 2B | 12 | 0 | 0 | 12 |
peripheral myelin protein 22 isoform 1 | 13 | 0 | 0 | 13 |
transient receptor potential cation channel subfamily V member 1 | 3 | 0 | 0 | 3 |
Beta-2 adrenergic receptor | 0 | 6 | 0 | 7 |
Beta-1 adrenergic receptor | 0 | 5 | 1 | 7 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 5A | 0 | 4 | 0 | 4 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
Transporter | 0 | 6 | 0 | 6 |
Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 16 | 0 | 0 | 16 |
Transporter | 0 | 15 | 1 | 17 |
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
Amyloid-beta precursor protein | 1 | 3 | 0 | 4 |
Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Tryptophan 5-hydroxylase 1 | 0 | 4 | 0 | 4 |
Liver carboxylesterase 1 | 0 | 2 | 0 | 3 |
Lysosomal Pro-X carboxypeptidase | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 2 | 0 | 2 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 3 | 0 | 3 |
Leukotriene B4 receptor 1 | 0 | 1 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Leukotriene B4 receptor 2 | 0 | 1 | 0 | 2 |
Cytochrome P450 2D1 | 0 | 3 | 0 | 3 |
Cytochrome P450 2D26 | 0 | 3 | 0 | 3 |
Cytochrome P450 2D3 | 0 | 3 | 0 | 3 |
Kappa-type opioid receptor | 0 | 4 | 2 | 8 |
Mu-type opioid receptor | 0 | 5 | 2 | 10 |
Cytochrome P450 2D4 | 0 | 3 | 0 | 3 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 4 | 0 | 4 |
Carbonic anhydrase | 0 | 2 | 0 | 6 |
Carbonic anhydrase 15 | 0 | 3 | 0 | 7 |
Chain A, N-methyl-D-aspartate Receptor Subunit 1 | 0 | 1 | 0 | 1 |
Chain A, N-methyl-D-aspartate Receptor Subunit 1 | 0 | 1 | 0 | 1 |
Chain A, N-methyl-D-aspartate Receptor Subunit 1 | 0 | 1 | 0 | 1 |
D-alanine--D-alanine ligase | 0 | 1 | 0 | 1 |
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase | 0 | 1 | 0 | 1 |
15-lipoxygenase, partial | 10 | 0 | 0 | 10 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 5 | 0 | 6 |
Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid | 0 | 2 | 2 | 4 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 2 | 4 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 2 | 4 |
endonuclease IV | 9 | 0 | 0 | 9 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 3 | 0 | 0 | 3 |
runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
Glutamate receptor 1 | 1 | 2 | 2 | 5 |
Glutamate receptor 3 | 1 | 2 | 2 | 5 |
Glutamate receptor 4 | 1 | 2 | 2 | 5 |
Caspase-7 | 2 | 0 | 0 | 2 |
eyes absent homolog 2 isoform a | 2 | 0 | 0 | 2 |
Alpha-synuclein | 3 | 2 | 0 | 5 |
TAR DNA-binding protein 43 | 8 | 0 | 0 | 8 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 4 |
Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Acetylcholinesterase | 0 | 4 | 0 | 4 |
Acetylcholinesterase | 0 | 3 | 0 | 3 |
Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
Beta-secretase 1 | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 3 | 0 | 3 |
Acetylcholine receptor subunit epsilon | 0 | 1 | 1 | 2 |
Acyl-CoA:cholesterol acyltransferase | 0 | 2 | 0 | 2 |
Carboxylic ester hydrolase | 0 | 2 | 0 | 3 |
Carboxylic ester hydrolase | 0 | 5 | 0 | 5 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 2 |
Glycine receptor subunit alpha-1 | 0 | 0 | 3 | 3 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 2 | 0 | 1 | 1 | 2 |
N-arachidonyl glycine receptor | 0 | 0 | 1 | 1 |
Lysophosphatidylserine lipase ABHD12 | 0 | 1 | 0 | 1 |
Monoglyceride lipase | 0 | 1 | 0 | 1 |
Monoacylglycerol lipase ABHD6 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 2 | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 3 |
Delta-type opioid receptor | 0 | 11 | 3 | 14 |
Mu-type opioid receptor | 0 | 12 | 4 | 16 |
Kappa-type opioid receptor | 0 | 6 | 3 | 9 |
Kappa-type opioid receptor | 0 | 9 | 1 | 11 |
Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 0 | 2 | 2 |
Voltage-dependent T-type calcium channel subunit alpha-1H | 0 | 0 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit beta-1 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 2 | 0 | 2 |
Voltage-dependent T-type calcium channel subunit alpha-1I | 0 | 0 | 1 | 1 |
Prostaglandin D2 receptor 2 | 0 | 1 | 0 | 1 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
nonstructural protein 1 | 8 | 0 | 0 | 8 |
flap endonuclease 1 | 16 | 0 | 0 | 16 |
urokinase-type plasminogen activator precursor | 7 | 0 | 0 | 7 |
plasminogen precursor | 7 | 0 | 0 | 7 |
urokinase plasminogen activator surface receptor precursor | 7 | 0 | 0 | 7 |
muscleblind-like protein 1 isoform 1 | 6 | 0 | 0 | 6 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
Thymidylate synthase | 0 | 1 | 0 | 1 |
Aromatase | 0 | 1 | 0 | 1 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 9 | 0 | 0 | 9 |
Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
Cytochrome P450 2C8 | 0 | 5 | 0 | 5 |
Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily C member 1 | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 5 | 0 | 5 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Beta-3 adrenergic receptor | 0 | 6 | 1 | 7 |
Androgen receptor | 0 | 2 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 2 | 0 | 2 |
Chain A, ACETYLCHOLINESTERASE | 0 | 1 | 0 | 1 |
Chain A, Acetylcholinesterase | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit rho-3 | 0 | 0 | 1 | 1 |
Hsf1 protein | 0 | 0 | 2 | 3 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 9 | 0 | 0 | 9 |
Histone deacetylase 3 | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 4 | 4 |
Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 2 | 2 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent taurine transporter | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 3 | 0 | 3 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 3 | 0 | 3 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
Histone deacetylase 1 | 0 | 3 | 0 | 3 |
Sterol O-acyltransferase 1 | 0 | 0 | 1 | 1 |
Histone deacetylase 7 | 0 | 3 | 0 | 3 |
Histone deacetylase 2 | 0 | 3 | 0 | 3 |
Polyamine deacetylase HDAC10 | 0 | 3 | 0 | 3 |
Histone deacetylase 11 | 0 | 3 | 0 | 3 |
Histone deacetylase 8 | 0 | 3 | 0 | 3 |
Platelet glycoprotein VI | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 3 | 0 | 3 |
Histone deacetylase 9 | 0 | 3 | 0 | 3 |
Histone deacetylase 5 | 0 | 3 | 0 | 3 |
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 8 | 0 | 0 | 8 |
Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
Glutathione reductase, mitochondrial | 0 | 4 | 0 | 4 |
Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 0 | 2 | 2 |
ATP-citrate synthase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 1 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 1 | 2 | 3 |
Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
Glutamate receptor 1 | 0 | 2 | 1 | 3 |
Glutamate receptor 2 | 0 | 2 | 1 | 3 |
Glutamate receptor 3 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
Glutamate receptor 4 | 0 | 2 | 1 | 3 |
Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Amino acid transporter | 0 | 1 | 0 | 1 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
Cocaine esterase | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 3 |
Vitamin D-binding protein | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
C-8 sterol isomerase | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 4 | 0 | 4 |
Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Zinc finger protein 664 | 0 | 1 | 0 | 1 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Protease | 0 | 2 | 0 | 2 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 9 | 0 | 0 | 9 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Plasma kallikrein | 0 | 0 | 0 | 4 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 7 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 7 |
Carbonic anhydrase | 0 | 1 | 0 | 6 |
Carbonic anhydrase | 0 | 2 | 0 | 7 |
Carbonic anhydrase | 0 | 2 | 0 | 7 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 6 |
ClpP | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
Gap junction alpha-1 protein | 0 | 1 | 0 | 1 |
Gap junction beta-2 protein | 0 | 1 | 0 | 1 |
Acyl-protein thioesterase 1 | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 2 | 0 | 2 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Synaptic vesicle glycoprotein 2A | 0 | 2 | 0 | 2 |
dopamine D1 receptor | 8 | 0 | 0 | 8 |
WRN | 2 | 0 | 0 | 2 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
pyruvate kinase | 1 | 0 | 0 | 1 |
hexokinase-4 isoform 1 | 3 | 0 | 0 | 3 |
glucokinase regulatory protein | 3 | 0 | 0 | 3 |
DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosinase | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 3 | 0 | 4 |
SLC16A10 protein | 0 | 0 | 0 | 3 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 3 |
phosphoglycerate kinase | 2 | 0 | 0 | 2 |
Beta-2 adrenergic receptor | 0 | 4 | 1 | 5 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1E | 0 | 2 | 0 | 2 |
D | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Cysteinyl leukotriene receptor 1 | 0 | 1 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
DNA polymerase III, partial | 2 | 0 | 0 | 2 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 3 | 0 | 0 | 3 |
Histidine decarboxylase | 0 | 0 | 2 | 2 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 2 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Acetylcholine receptor subunit beta-like 2 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Acetylcholine-binding protein | 0 | 1 | 1 | 2 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 1 | 2 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
Liver carboxylesterase B-1 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 2 | 2 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Soluble acetylcholine receptor | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Integrin beta | 0 | 0 | 1 | 1 |
Glycoprotein IIb | 0 | 0 | 1 | 1 |
Parkin | 2 | 0 | 0 | 2 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
perilipin-5 | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 3 | 0 | 0 | 3 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
polyadenylate-binding protein 1 | 0 | 1 | 0 | 1 |
bcl-2-related protein A1 | 0 | 2 | 0 | 2 |
MCOLN3 protein | 0 | 0 | 1 | 1 |
transient receptor potential cation channel, subfamily N, member 1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor DM1 | 0 | 2 | 0 | 2 |
Mineralocorticoid receptor | 0 | 0 | 1 | 1 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
Valosin-containing protein | 0 | 1 | 0 | 1 |
microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 0 | 0 | 2 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
Oxytocin receptor | 0 | 0 | 1 | 1 |
Quinolone resistance protein NorA | 0 | 2 | 0 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Beta-adrenergic receptor kinase 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 1 | 1 | 2 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Rhodopsin kinase GRK1 | 0 | 1 | 0 | 1 |
G protein-coupled receptor kinase 5 | 0 | 1 | 0 | 1 |
G protein-coupled receptor kinase 5 | 0 | 1 | 0 | 1 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
Rhodopsin kinase GRK1 | 0 | 1 | 0 | 1 |
Beta-adrenergic receptor kinase 1 | 0 | 0 | 0 | 1 |
ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 2 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Retinal dehydrogenase 1 | 0 | 1 | 0 | 1 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 1 | 1 | 3 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 3 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
E3 ubiquitin-protein ligase XIAP | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 2 | 0 | 2 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
XBP1 | 0 | 1 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 3 | 0 | 0 | 3 |
DNA damage-inducible transcript 3 protein | 0 | 1 | 0 | 1 |
Ubiquitin carboxyl-terminal hydrolase 1 | 0 | 2 | 0 | 2 |
WD repeat-containing protein 48 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 1 | 4 |
luciferase | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Glucocorticoid receptor | 0 | 2 | 1 | 8 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 3 | 0 | 3 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 2 |
Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
Mcl-1 | 0 | 1 | 0 | 1 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 1 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-6 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 2 | 0 | 3 |
Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
DNA topoisomerase 1 | 0 | 2 | 0 | 2 |
Chromaffin granule amine transporter | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 3 | 1 | 4 |
Synaptic vesicular amine transporter | 0 | 3 | 1 | 4 |
Synaptic vesicular amine transporter | 0 | 2 | 0 | 2 |
Sphingosine kinase 2 | 0 | 2 | 0 | 2 |
Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2B1 | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 0 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 0 | 0 | 1 |
Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Beta-carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Carbonic anhydrase, alpha family | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Delta carbonic anhydrase | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Nrf2 | 1 | 0 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
toll-like receptor 9 | 0 | 1 | 0 | 1 |
caspase recruitment domain family, member 15 | 0 | 1 | 0 | 1 |
neurotensin receptor type 1 | 0 | 0 | 1 | 1 |
receptor-interacting serine/threonine-protein kinase 2 isoform 1 | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
Cathepsin D | 0 | 1 | 0 | 1 |
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-related protein 11 | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 1 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 1 | 0 | 1 |
Lysozyme C-1 | 0 | 1 | 0 | 1 |
Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
Protein kinase C alpha type | 0 | 1 | 0 | 1 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Protein kinase C delta type | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
Protein kinase C zeta type | 0 | 1 | 0 | 1 |
Protein kinase C gamma type | 0 | 1 | 0 | 1 |
Protein kinase C beta type | 0 | 1 | 0 | 1 |
Protein kinase C eta type | 0 | 1 | 0 | 1 |
Calcium-dependent protein kinase 4 | 0 | 1 | 0 | 1 |
Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
Protein kinase C theta type | 0 | 1 | 0 | 1 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Transthyretin | 0 | 0 | 0 | 1 |
Thyroid hormone receptor alpha | 0 | 2 | 2 | 4 |
Thyroid hormone receptor beta | 0 | 2 | 2 | 4 |
Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 1 |
Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Tryprostatin B synthase | 0 | 0 | 0 | 1 |
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
Tissue factor | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 1 | 0 | 1 |
M-phase inducer phosphatase 1 | 0 | 1 | 0 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
Aspartate aminotransferase, cytoplasmic | 0 | 1 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |